Scheme Reciprocity

It is for the purpose of multitude cord blood databases that BIONET has established an innovative storage scheme Reciprocity, comprising private banking and public donation. This scheme allows participants entitle to most of the primary rights as enrolled in private banking with considerably less investment, such as to access public banking database when in need of searching for matches. The program has been proven successfully responsive as the database of BIONET has grown rapidly, currently holding the fourth position on Bone Marrow Donors Worldwide (BMDW). The private database of BIONET is also linked throughout foreign partners such as BMDW, APCBBC, and BIONET donation database.

BIONET's Scarce Core Tech

The sources of stem cell are extremely diversified; stem cells isolated form different sources have various potentials accordingly in terms of medical applications. BIONET had made a breakthrough of stem cells research for practical applications combining stem cells form distinct sources. These distinctions are hematopoietic stem cell (HSC), mesenchymal stem cell (MSC), dental pulp stem cell (DPSC), and peripheral blood stem cell (PBSC).

Since the first attempt of HSC transplant in 1988, there has been thousands of successful cases of which treating blood diseases: Thalassemia, Leukemia, inherited inefficiency, immune inefficiency, and repairing hematopoietic system post chemotherapy.br />
Research of MSCs is mainly for regenerative medicines in the fields of treating Myocardial infarction, Parkinson's disease, et al. It has been reported that HSC/MSC co-infusion for hematopoietic regeneration may enhance engraftment rate. Also a number of domestic clinical studies in progress are investigating MSC for stroke, degenerative Arthritis, as well as differentiation study for diabetics in animal model.

Currently the understanding of DPSC has focused in Neurogenesis and Asteogenesis, as it clearly distinguished from the therapeutic applications of HSC and MSC, and they are all valuable sources of somatic stem cell.